Anlon Healthcare Limited (AHCL) — Announcement | 11 July 2026

StockFin.ai

Try Free

📢 Key Event
Company incorporates subsidiary ANLON BIOLOGICS PRIVATE LIMITED

💡 Investor Takeaway
The subsidiary creates a dedicated platform for high-growth medical device segments without immediate financial strain.

Anlon Healthcare announced incorporation of ANLON BIOLOGICS PRIVATE LIMITED as a wholly-owned subsidiary effective July 10, 2026, to develop surgical implants and medical devices that complement its pain management business. The new entity has authorized and paid-up capital of ₹1 million, with Anlon Healthcare subscribing to 65% of its equity shares for ₹650,000 in cash.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AHCL ✨ Ask AI About This

About Anlon Healthcare Limited (AHCL)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹709.57 Cr

View full AHCL stock details →

📡 Get AI alerts when AHCL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AHCL — Free

💡 Ask AI about this filing

"How does this affect AHCL margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More AHCL filings

See all AHCL filings →

🔥 Also filed on 11 July 2026

AFIL Akme Fintrade (India) Limited Annual Report DLF DLF Limited Annual Report AVANTEL Avantel Limited Corporate Action DLF DLF Limited Corporate Action BAJAJCON Bajaj Consumer Care Limited Annual Report BILVYAPAR BIL VYAPAR LIMITED Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when AHCL files new disclosures

Track AHCL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AHCL — Free

Free account · 2 AI queries/day